Search Results - "LAVERGNE, Valery"

Refine Results
  1. 1
  2. 2

    Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples by Eckbo, Eric J., Locher, Kerstin, Caza, Melissa, Li, Lisa, Lavergne, Valery, Charles, Marthe

    “…The BioFire® COVID-19 Test and Respiratory Panel 2.1 (RP2.1) are rapid, fully automated assays for the detection of severe acute respiratory syndrome…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    The impact of various platelet indices as prognostic markers of septic shock by Gao, Yanxia, Li, Yi, Yu, Xuezhong, Guo, Shigong, Ji, Xu, Sun, Tongwen, Lan, Chao, Lavergne, Valery, Ghannoum, Marc, Li, Li

    Published in PloS one (13-08-2014)
    “…Platelet indices, including mean platelet volume (MPV), are readily available blood tests, although their prognostic value in patients with septic shock has…”
    Get full text
    Journal Article
  7. 7

    Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup by Mactier, Robert, MD, Laliberté, Martin, MD, MSc, Mardini, Joelle, MD, Ghannoum, Marc, MD, Lavergne, Valery, MD, MSc, Gosselin, Sophie, MD, Hoffman, Robert S., MD, Nolin, Thomas D., PharmD, PhD

    Published in American journal of kidney diseases (01-09-2014)
    “…The EXTRIP (Extracorporeal Treatments in Poisoning) Workgroup conducted a systematic review of barbiturate poisoning using a standardized evidence-based…”
    Get full text
    Journal Article
  8. 8

    Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping by Li, Yi, Ghannoum, Marc, Deng, Chuntao, Gao, Yanxia, Zhu, Huadong, Yu, Xuezhong, Lavergne, Valery

    “…Highlights • Lymphocyte subtyping is useful for predicting Pneumocystis jirovecii pneumonia (PCP) and related mortality in non-HIV patients. • A CD3+ cell…”
    Get full text
    Journal Article
  9. 9

    Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis by Goupil, Rémi, Brachemi, Soumeya, Nadeau-Fredette, Annie-Claire, Déziel, Clément, Troyanov, Yves, Lavergne, Valery, Troyanov, Stéphan

    “…ANCA-associated vasculitis (AAV) is treated with potent immunosuppressive regimens. This study sought to determine risk factors associated with infections…”
    Get full text
    Journal Article
  10. 10

    Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup by Ghannoum, Marc, Gosselin, Sophie, Hoffman, Robert S, Lavergne, Valery, Mégarbane, Bruno, Hassanian-Moghaddam, Hossein, Rif, Maria, Kallab, Siba, Bird, Steven, Wood, David M, Roberts, Darren M

    Published in Critical care (London, England) (10-02-2023)
    “…Ethylene glycol (EG) is metabolized into glycolate and oxalate and may cause metabolic acidemia, neurotoxicity, acute kidney injury (AKI), and death…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Extracorporeal treatment for valproic acid poisoning: Systematic review and recommendations from the EXTRIP workgroup by Ghannoum, Marc, Laliberté, Martin, Nolin, Thomas D., MacTier, Robert, Lavergne, Valery, Hoffman, Robert S., Gosselin, Sophie

    Published in Clinical toxicology (Philadelphia, Pa.) (01-06-2015)
    “…Abstract Background. The EXtracorporeal TReatments In Poisoning (EXTRIP) workgroup presents its systematic review and clinical recommendations on the use of…”
    Get full text
    Journal Article
  14. 14

    Extracorporeal treatment for theophylline poisoning: Systematic review and recommendations from the EXTRIP workgroup by Ghannoum, Marc, Wiegand, Timothy J., Liu, Kathleen D., Calello, Diane P., Godin, Melanie, Lavergne, Valery, Gosselin, Sophie, Nolin, Thomas D., Hoffman, Robert S.

    Published in Clinical toxicology (Philadelphia, Pa.) (01-05-2015)
    “…Abstract Background. The Extracorporeal Treatments in Poisoning workgroup was created to provide evidence-based recommendations on the use of extracorporeal…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration by Hayes, Bryan D., Gosselin, Sophie, Calello, Diane P., Nacca, Nicholas, Rollins, Carol J., Abourbih, Daniel, Morris, Martin, Nesbitt-Miller, Andrea, Morais, José A., Lavergne, Valéry

    Published in Clinical toxicology (Philadelphia, Pa.) (27-05-2016)
    “…Background: Intravenous lipid emulsions (ILEs) were initially developed to provide parenteral nutrition. In recent years, ILE has emerged as a treatment for…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Risk Factors and Consequences of Hyperaluminemia in a Peritoneal Dialysis Cohort by LAVERGNE, Valery, GHANNOUM, Marc, CHRISTIE, Megan, VO, Van, TAM, Paul W, TING, Robert, SIKANETA, Tabo

    Published in Peritoneal dialysis international (01-11-2012)
    “…Widespread Al toxicity is unusual today. In 2005, Canadian peritoneal dialysis (PD) centers reported widespread hyperaluminemia in patients using dialysates…”
    Get full text
    Journal Article